Profil bibliographique

Thomas G. O’Riordan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

109Publications signalées

7195Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Inhalation and Respiratory Drug DeliveryAsthma and respiratory diseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease (COPD) ResearchCystic Fibrosis Research Advances

Publications récentes

Accès ouvert 2025 articleOpenAlex

Long-acting β2 agonist (LABA) with a long-acting muscarinic receptor antagonist (LAMA) promotes human airway smooth muscle (HASM) relaxation and circumvents β2 adrenergic receptor tachyphylaxis

Joseph A. Jude, N. Karmacharya, Rinzhin T. Sherpa, Thomas G. O’Riordan et autres

0 citationsRespiratory Research

Accès ouvert 2025 articleOpenAlex

Leveraging Machine Learning and Real-World Data to Predict Chronic Obstructive Pulmonary Disease Exacerbations

Reynold A. Panettieri, Jason Roy, Natalia Gontarczyk Uczkowski, Allison Tyler et autres

2 citationsInternational Journal of COPD

Accès ouvert 2024 conference-abstractOpenAlex

Leveraging Machine Learning and Real-world Data to Predict Chronic Obstructive Pulmonary Disease Exacerbations

Reynold A. Panettieri, Jason Roy, N. Gontarczyk Uczkowski, A Tyler et autres

0 citations

Accès ouvert 2024 editorialOpenAlex

Optimizing Aerosolized Drug Delivery in Clinical Trials in Patients Undergoing Mechanical Ventilation

Thomas G. O’Riordan

1 citationJournal of Aerosol Medicine and Pulmonary Drug Delivery

Accès ouvert 2024 articleOpenAlex

Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities

Paneez Khoury, Florence Roufosse, Fei Li Kuang, Steven J. Ackerman et autres

6 citationsJournal of Leukocyte Biology

Accès ouvert 2023 articleOpenAlex

LEVERAGING ARTIFICIAL INTELLIGENCE TO CREATE A CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION RISK ALGORITHM

ANNA ZAKUSYLO, Kristin Wrobleski, Allison Tyler, Jason Roy et autres

2 citationsCHEST Journal

2022 articleOpenAlex

Building on Strong Foundations: The Next Chapter in the Story of the Journal of Aerosol Medicine and Pulmonary Drug Delivery

Thomas G. O’Riordan

0 citationsJournal of Aerosol Medicine and Pulmonary Drug Delivery

2021 articleOpenAlex

Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis

William W. Busse, Sally E. Wenzel, Thomas B. Casale, J. Mark FitzGerald et autres

147 citationsThe Lancet Respiratory Medicine

Accès ouvert 2020 articleOpenAlex

Airway drug pharmacokinetics via analysis of exhaled breath condensate

Thomas G. O’Riordan, John H. Ansede, Melissa Johnson, Charles R. Esther et autres

0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)

2020 conference-abstractOpenAlex

Dupilumab Improved Pre-Bronchodilator FEV 1 in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma, Regardless of Presence of Perennial Aeroallergen-Specific IgE: LIBERTY ASTHMA QUEST Study

Jonathan Corren, D.J. Jackson, Thomas B. Casale, Nadia Daizadeh et autres

0 citations

Accès ouvert 2020 articleOpenAlex

Baseline FeNO as a Prognostic Biomarker for Subsequent Severe Asthma Exacerbations in Patients With Uncontrolled, Moderate-to-Severe Asthma Receiving Placebo in the LIBERTY ASTHMA QUEST Study

William W. Busse, Ian Pavord, Sally E. Wenzel, Eric D. Bateman et autres

3 citationsJournal of Allergy and Clinical Immunology

Accès ouvert 2019 articleOpenAlex

Risk factors for disease progression in idiopathic pulmonary fibrosis

Ganesh Raghu, Brett Ley, Kevin M. Brown, Vincent Cottin et autres

35 citationsThorax

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.